Patients with a history of current evidence/risk of retinal vein occlusion (RVO) or central serous retinopathy (CSR)
Patients who meet any of the following exclusion criteria related to ocular disease will be excluded from study entry:\r\n* Known risk factors for ocular toxicity, consisting of any of the following:\r\n** History of serous retinopathy\r\n** History of retinal vein occlusion (RVO)\r\n** Evidence of ongoing serous retinopathy or RVO at screening
History or evidence of ongoing serous retinopathy or retinal vein occlusion (RVO) at baseline
Patients with a history or current evidence of CSR (central serous retinopathy), RVO (rential vein occlusion), or ophthalmopathy present at baseline that would be considered a risk factor for CSR or RVO
A history of current evidence/risk of retinal vein occlusion (RVO) or central serous retinopathy (CSR)
Ophthalmological conditions as follows:\r\n* Current or past history of retinal pigment epithelial detachment (RPED)/central serous retinopathy (CSR) or retinal vein occlusion\r\n* Uncontrolled glaucoma (irrespective of intraocular pressure [IOP])
History of serous retinopathy, retinal vein occlusion (RVO), or evidence of ongoing serous retinopathy or RVO at baseline
Known risk factors for ocular toxicity, consisting of any of the following:\r\n* presence of serous retinopathy within 6 months of protocol enrollment\r\n* presence of retinal vein occlusion (RVO) within 6 months of protocol enrollment.
Any corneal or retinal abnormality likely to increase the risk of eye toxicity, such as:\r\n* Current corneal pathology such as keratitis, keratoconjunctivitis, keratopathy, corneal abrasion, inflammation or ulceration\r\n* Uncontrolled glaucoma despite standard of care therapy\r\n* Diabetic retinopathy with macular edema\r\n* Known active wet, age-related macular degeneration (AMD)\r\n* Known central serous retinopathy (CSR) or retinal vascular occlusion (RVO)
Ophthalmological conditions as follows: current or past history of retinal pigment epithelial detachment (RPED)/central serous retinopathy (CSR) or retinal vein occlusion; or intraocular pressure (IOP) > 21 mmHg or uncontrolled glaucoma (irrespective of IOP)
Patients with known history of serous retinopathy will not be eligible
History or current evidence/risk of retinal vein occlusion (RVO) or central serous retinopathy (CSR)
Ophthalmological conditions as follows: \r\n• Intra-ocular pressure > 21 mmHg, or uncontrolled glaucoma (irrespective of intra-ocular pressure) \r\n• Current or past history of central serous retinopathy or retinal vein occlusion
Patients with the following ophthalmological findings/conditions:\r\n* Intraocular pressure > 21 mmHg, or uncontrolled glaucoma (irrespective of intraocular pressure)\r\n* Current or past history of central serious retinopathy or retinal vein occlusion
History or current evidence of central serous retinopathy (CSR), retinal vein occlusion (RVO)
History or current evidence of central serous retinopathy (CSR) or retinal vein occlusion (RVO)
Ophthalmological conditions as follows:\r\n* Intra-ocular pressure > 21 mmHg, or uncontrolled glaucoma (irrespective of intra-ocular pressure)\r\n* Current or past history of central serous retinopathy or retinal vein occlusion
History of or current evidence / risk of retinal vein occlusion (RVO) central serous retinopathy (CSR), or glaucoma with intraocular pressures ? 21 mmHg or other pre-existing ocular conditions that may put the patient at risk for ocular toxicities
Ophthalmologic conditions, including any of the following:\r\n* Current or past history of central serous retinopathy\r\n* Current or past history of retinal vein occlusion\r\n* Intraocular pressure (IOP) > 21 mmHg or uncontrolled glaucoma
Known ophthalmological conditions as follows: intra-ocular pressure > 21 mmHg, or uncontrolled glaucoma (irrespective of intra-ocular pressure); current or past history of central serous retinopathy or retinal vein occlusion
CLINICAL/LABORATORY CRITERIA: Patients must not have untreated or unresolved retinopathy or have a history (or current evidence) of retinal vein occlusion determined by an ophthalmology exam within 42 days prior to registration
History of predisposition to retinal vein occlusion or central serous retinopathy
History of predisposition to retinal vein occlusion or central serous retinopathy
History of or current evidence of central serous retinopathy (CSR), retinal vein occlusion (RVO) or history of retinal degenerative disease
Patients with a history or current known evidence of central serous retinopathy (CSR), retinal vein occlusion (RVO) or ophthalmopathy at baseline that would be considered a risk factor for CSR or RVO
A history or current evidence/risk of retinal vein occlusion or central serous retinopathy
History or current evidence of retinal vein occlusion (RVO) or central serous retinopathy (CSR)
History or current evidence/risk of retinal vein occlusion (RVO) or central serous retinopathy (CSR)
History of central serous retinopathy or retinal vein occlusion
Patients with baseline risk factors for central serous retinopathy or retinal vein occlusion such as evidence of new optic disc cupping, evidence of new visual field defects, and intraocular pressure > 21 mmHg
History or current evidence of retinal vein occlusion (RVO) or central serous retinopathy (CSR).
A history or current evidence/risk of retinal vein occlusion or central serous retinopathy
History of or current risk for retinal vein occlusion (RVO) or central serous retinopathy (CSR)
A history or current evidence/risk of retinal vein occlusion (RVO) or Central serous retinopathy (CSR) including
History of retinal vein occlusion, central serous retinopathy or glaucoma.
Visible retinal pathology as assessed by ophthalmologic exam that is considered a risk factor for retinal vein occlusion or central serous retinopathy.
History or evidence of retinal pathology according to protocol-defined criteria, including serous retinopathy